Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-28T04:30:27.425Z Has data issue: false hasContentIssue false

Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy

Published online by Cambridge University Press:  12 April 2010

E. Frank*
Affiliation:
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
G. B. Cassano
Affiliation:
Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Italy
P. Rucci
Affiliation:
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
W. K. Thompson
Affiliation:
Department of Psychiatry, University of California at San Diego, San Diego, CA, USA
H. C. Kraemer
Affiliation:
Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA
A. Fagiolini
Affiliation:
Department of Neuroscience, Psychiatry Division, University of Siena School of Medicine, Siena, Italy
L. Maggi
Affiliation:
Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Italy
D. J. Kupfer
Affiliation:
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
M. K. Shear
Affiliation:
School of Social Work, Columbia University, New York, NY, USA
P. R. Houck
Affiliation:
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
S. Calugi
Affiliation:
Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Italy
V. J. Grochocinski
Affiliation:
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
P. Scocco
Affiliation:
Mental Health Department, ULSS 16, Padua, Italy
J. Buttenfield
Affiliation:
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
R. N. Forgione
Affiliation:
Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Italy
*
*Address for correspondence: E. Frank, Ph.D., University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, PA15213, USA. (Email: franke@upmc.edu)

Abstract

Background

Although many studies suggest that, on average, depression-specific psychotherapy and antidepressant pharmacotherapy are efficacious, we know relatively little about which patients are more likely to respond to one versus the other. We sought to determine whether measures of spectrum psychopathology are useful in deciding which patients with unipolar depression should receive pharmacotherapy versus depression-specific psychotherapy.

Method

A total of 318 adult out-patients with major depression were randomly assigned to escitalopram pharmacotherapy or interpersonal psychotherapy (IPT) at academic medical centers at Pittsburgh, Pennsylvania and Pisa, Italy. Our main focus was on predictors and moderators of time to remission on monotherapy at 12 weeks.

Results

Participants with higher scores on the need for medical reassurance factor of the Panic–Agoraphobic Spectrum Self-Report (PAS-SR) had more rapid remission with IPT and those with lower scores on the psychomotor activation factor of the Mood Spectrum Self-Report (MOODS-SR) experienced more rapid remission with selective serotonin reuptake inhibitor (SSRI) pharmacotherapy. Non-specific predictors of longer time to remission with monotherapy included several panic spectrum and mood spectrum factors and the Social Phobia Spectrum (SHY) total score. Higher baseline scores on the 17- and 25-item Hamilton Depression Rating Scales (HAMD-17 and HAMD-25) and the Work and Social Adjustment Scale (WSAS) also predicted a longer time to remission, whereas being married predicted a shorter time to remission.

Conclusions

This exploratory study identified several non-specific predictors but few moderators of psychotherapy versus pharmacotherapy outcome. It offers useful indicators of the characteristics of patients that are generally difficult to treat, but only limited guidance as to who benefits from IPT versus SSRI pharmacotherapy.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akiskal, HS (2007). The emergence of the bipolar spectrum: validation along clinical epidemiologic and familial-genetic lines. Psychopharmacology Bulletin 40, 99–115.Google ScholarPubMed
APA (2000). Handbook of Psychiatric Measures, 1st edn. American Psychiatric Association: Washington, DC.Google Scholar
Barber, JP, Muenz, LR (1996). The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. Journal of Consulting and Clinical Psychology 64, 951958.CrossRefGoogle ScholarPubMed
Beck, AT, Rush, AJ, Shaw, BF, Emery, G (1979). Cognitive Therapy of Depression. Guilford Press: New York.Google Scholar
Brückl, TM, Wittchen, HU, Höfler, M, Pfister, H, Schneider, S, Lieb, R (2007). Childhood separation anxiety and the risk of subsequent psychopathology: results from a community study. Psychotherapy and Psychosomatics 76, 4756.CrossRefGoogle ScholarPubMed
Cassano, GB, Benvenuti, A, Miniati, M, Calugi, S, Mula, M, Maggi, L, Rucci, P, Fagiolini, A, Perris, F, Frank, E (2009 a). The factor structure of lifetime depressive spectrum in patients with unipolar depression. Journal of Affective Disorders 115, 8799.CrossRefGoogle ScholarPubMed
Cassano, GB, Michelini, S, Shear, MK, Coli, E, Maser, JD, Frank, E (1997). The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms. American Journal of Psychiatry 154, 2738.Google Scholar
Cassano, GB, Mula, M, Rucci, P, Miniati, M, Frank, E, Kupfer, DJ, Oppo, A, Calugi, S, Maggi, L, Gibbons, R, Fagiolini, A (2009 b). The structure of lifetime manic-hypomanic spectrum. Journal of Affective Disorders 112, 5970.CrossRefGoogle ScholarPubMed
Cassano, GB, Rucci, P, Frank, E, Fagiolini, A, Dell'Osso, L, Shear, MK, Kupfer, DJ (2004). The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. American Journal of Psychiatry 161, 12641269.CrossRefGoogle ScholarPubMed
Dell'Osso, L, Armani, A, Rucci, P, Frank, E, Fagiolini, A, Corretti, G, Shear, MK, Grochocinski, VJ, Maser, JD, Endicott, J, Cassano, GB (2002 a). Measuring mood spectrum: comparison of interview (SCI-MOODS) and self-report (MOODS-SR) instruments. Comprehensive Psychiatry 43, 6973.CrossRefGoogle ScholarPubMed
Dell'Osso, L, Rucci, P, Cassano, GB, Maser, JD, Endicott, J, Shear, MK, Sarno, MK, Saettoni, M, Grochocinski, VJ, Frank, E (2002 b). Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments. Comprehensive Psychiatry 43, 8187.CrossRefGoogle ScholarPubMed
DeRubeis, RJ, Hollon, SD, Amsterdam, JD, Shelton, RC, Young, PR, Salomon, RM, O'Reardon, JP, Lovett, ML, Gladis, MM (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry 62, 409416.CrossRefGoogle ScholarPubMed
Dimidjian, S, Dobson, KS, Kohlenberg, RJ, Gallop, R, Markley, DK, Atkins, DC, Hollon, SD, Schmaling, KB, Addis, ME, McGlinchey, JB, Gollan, JK, Dunner, DL, Jacobson, NS (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658670.CrossRefGoogle ScholarPubMed
Dupont, WD, Plummer, WD (1997). PS power and sample size program available for free on the internet. Contemporary Clinical Trials 18, 274.CrossRefGoogle Scholar
Fagiolini, A, Dell'Osso, L, Pini, S, Armani, A, Bouanani, S, Rucci, P, Cassano, GB, Endicott, J, Maser, JD, Shear, MK, Grochocinski, VJ, Frank, E (1999). Validity and reliability of a new instrument for assessing mood symptomatology: the Structured Clinical Interview for Mood Spectrum (SCI-MOODS). International Journal of Methods in Psychiatric Research 8, 7182.CrossRefGoogle Scholar
Fava, M, Rush, AJ, Alpert, JE, Balasubramani, GK, Wisniewski, SR, Carmin, CN, Biggs, MM, Zisook, S, Leuchter, A, Howland, R, Warden, D, Trivedi, MH (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342351.CrossRefGoogle Scholar
Fournier, JC, DeRubeis, RJ, Shelton, RC, Gallop, R, Amsterdam, JD, Hollon, SD (2008). Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. British Journal of Psychiatry 192, 124129.CrossRefGoogle ScholarPubMed
Fournier, JC, DeRubeis, RJ, Shelton, RC, Hollon, SD, Amsterdam, JD, Gallop, R (2009). Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 77, 775787.CrossRefGoogle ScholarPubMed
Frank, E, Cassano, GB, Rucci, P, Fagiolini, A, Maggi, L, Kraemer, HC, Kupfer, DJ, Pollock, B, Bies, R, Nimgaonkar, V, Pilkonis, P, Shear, MK, Thompson, WK, Grochocinski, VJ, Scocco, P, Buttenfield, J, Forgione, RN (2008). Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression. Clinical Trials 5, 253261.CrossRefGoogle ScholarPubMed
Frank, E, Shear, MK, Rucci, P, Cyranowski, JM, Endicott, J, Fagiolini, A, Grochocinski, VJ, Houck, P, Kupfer, DJ, Maser, JD, Cassano, GB (2000). Influence of panic-agoraphobic spectrum symptomatology on treatment response in patients with recurrent major depression. American Journal of Psychiatry 157, 11011107.CrossRefGoogle Scholar
Hamilton, M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 5662.CrossRefGoogle ScholarPubMed
Klerman, GL, Weissman, MM, Rounsaville, BJ, Chevron, ES (1984). Interpersonal Psychotherapy of Depression. Basic Books: New York.Google Scholar
Kraemer, HC, Wilson, GT, Fairburn, CG, Agras, WS (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59, 877883.CrossRefGoogle ScholarPubMed
Leykin, Y, Amsterdam, JD, DeRubeis, RJ, Gallop, R, Shelton, RC, Hollon, SD (2007). Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology 75, 267276.CrossRefGoogle Scholar
Mundt, JC, Marks, IM, Shear, MK, Greist, JH (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 180, 461464.CrossRefGoogle Scholar
Phelps, JR, Ghaemi, SN (2006). Improving the diagnosis of bipolar disorder: predictive value of screening tests. Journal of Affective Disorders 92, 141148.CrossRefGoogle ScholarPubMed
Pini, S, Abelli, M, Mauri, M, Muti, M, Lazzetta, P, Banti, S, Cassano, GB (2005). Clinical correlates and significance of separation anxiety in patients with bipolar disorder. Bipolar Disorders 7, 370376.CrossRefGoogle ScholarPubMed
Rucci, P, Miniati, M, Oppo, A, Mula, M, Calugi, S, Frank, E, Shear, MK, Mauri, M, Pini, S, Cassano, GB (2009). The structure of lifetime panic-agoraphobic spectrum. Journal of Psychiatric Research 43, 366379.CrossRefGoogle ScholarPubMed
Rush, AJ, O'Neal, BL (1999). Patient Rated Inventory of Side Effects (PRISE): unpublished rating scale. University of Texas Southwestern Medical Center: Dallas.Google Scholar
Rush, AJ, Trivedi, MH, Wisniewski, SR, Nierenberg, AA, Stewart, JW, Warden, D, Niederehe, G, Thase, ME, Lavori, PW, Lebowitz, BD, McGrath, PJ, Rosenbaum, JF, Sackeim, HA, Kupfer, DJ, Luther, J, Fava, M (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163, 19051917.CrossRefGoogle ScholarPubMed
Shear, MK, Frank, E, Rucci, P, Fagiolini, A, Grochocinski, VJ, Houck, P, Cassano, GB, Kupfer, DJ, Endicott, J, Maser, JD, Mauri, M, Banti, S (2001). Panic-agoraphobic spectrum: reliability and validity of assessment instruments. Journal of Psychiatric Research 35, 5966.CrossRefGoogle ScholarPubMed
Sotsky, SM, Glass, DR, Shea, T, Pilkonis, PA, Collins, JF, Elkin, I, Watkins, JT, Imber, SD, Leber, WR, Moyer, J, Oliveri, ME (1991). Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. American Journal of Psychiatry 148, 997–1008.Google ScholarPubMed
Souery, D, Oswald, P, Massat, I, Bailer, U, Bollen, J, Demyttenaere, K, Kasper, S, Lecrubier, Y, Montgomery, S, Serretti, A, Zohar, J, Mendlewicz, J (2007). Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. Journal of Clinical Psychiatry 68, 10621070.CrossRefGoogle Scholar
Wagner, E, Frank, E, Steiner, S (1992). Discriminating maintenance treatments for recurrent depression: development and implementation of a rating scale. Journal of Psychotherapy Practice and Research 1, 280290.Google ScholarPubMed
Weissman, MM, Markowitz, JC, Klerman, GL (2000). Comprehensive Guide to Interpersonal Psychotherapy. Basic Books: New York.Google Scholar